台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    27.60
  • 漲跌
    ▲0.05
  • 漲幅
    +0.18%
  • 成交量
    523
  • 產業
    上市 生技醫療類股
  • 301人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
神隆 (1789)籌碼相關-富邦-信義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-信義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/0200.00128.8528.65-11,257-0.08%
2024/04/2900.00228.9029.10-21,228-0.16%
2024/04/2600.00128.6528.15-11,176-0.08%
2024/04/24127.7000.0027.9511,1580.09%
2024/04/2200.000.527.2027.45-0.51,154-0.04%
2024/04/12727.55427.4327.4531,0970.27%
2024/04/10128.752128.6828.70-201,040-1.92%
2024/04/082228.2600.0028.30229622.29%
2024/04/03427.20227.4327.7529190.22%
2024/04/02127.6500.0027.6018940.11%
2024/04/01127.50127.4527.4508850.00%
2024/03/29427.9300.0027.6548760.46%
2024/03/28527.8200.0027.6558210.61%
2024/03/1200.00525.5525.60-5576-0.87%
2024/01/0300.000.126.0026.10-0.1801-0.01%
2023/12/0600.00226.8026.90-2780-0.26%
2023/12/011426.9300.0026.85147571.85%
2023/11/081026.101026.0526.0507940.00%
2023/10/271026.501026.5026.4509500.00%
2023/10/191026.301026.3526.2501,2230.00%
2023/08/2200.00127.0027.00-13,102-0.03%
2023/08/11528.60128.7028.5543,0530.13%
2023/08/08131.9500.0030.9012,9850.03%
2023/08/0700.00332.1032.10-32,970-0.10%
2023/07/31132.20132.0531.8502,8750.00%
2023/07/2500.00632.8332.80-62,850-0.21%
2023/07/21531.5000.0031.5052,8010.18%
2023/07/20432.18432.9131.3002,6860.00%
2023/07/191234.171333.6433.35-12,390-0.04%
2023/07/18534.02334.2533.7022,2130.09%
2023/07/171031.001033.2033.2501,8910.00%
2023/07/141029.101130.3130.25-11,806-0.06%
2023/07/111029.601029.5029.4501,8590.00%
2023/07/101028.851029.4529.5001,8490.00%
2023/07/0400.000.330.1029.75-0.31,727-0.02%
2023/07/03129.60229.7529.75-11,703-0.06%
2023/06/30129.7000.0030.2511,6550.06%
2023/06/29129.35129.5529.5001,5840.00%
2023/06/2600.002528.9028.75-251,481-1.69%
2023/05/0800.00127.6027.55-11,167-0.09%
2023/05/0400.00728.5428.55-71,175-0.60%
2023/05/03328.4000.0028.3031,1680.26%
2023/05/0200.00328.8028.65-31,171-0.26%
2023/04/2800.00328.6528.40-31,154-0.26%
2023/04/27128.4000.0028.3011,0790.09%
2023/04/1400.00127.3527.00-1931-0.11%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章